Literature DB >> 34743675

Prevalence, risk factors and outcome of Mycoplasma pneumoniae infection among children in Uganda: a prospective study.

Rebecca Nantanda1, Freddie Bwanga2, Irene Najjingo1, Grace Ndeezi3, James K Tumwine3.   

Abstract

BACKGROUND: : Atypical bacteria cause 10-40% of all childhood pneumonia.. Data on the burden of atypical pneumonia in sub-Saharan Africa are limited. AIM: : To determine the prevalence, associated factors, and outcome of Mycoplasma pneumoniae infection in children with respiratory symptoms at Mulago National Referral Hospital, Kampala.
METHODS: : Children aged 2 months to 12 years with cough and/or difficult breathing and fast breathing were recruited. A clinical history and physical examination were undertaken. Blood samples for Mycoplasma pneumoniae IgM antibodies were taken at enrolment and Day 21 and induced sputum for DNA-PCR. Admitted participants were followed for a maximum of 7 days or until discharge or death, whichever came first.
RESULTS: : A total of 385 children were enrolled, and, of these, 368 (95.6%) were <5 years. Overall, 60/385 (15.6%) participants tested positive for M. pneumoniae IgM and/or DNA-PCR. Of these, 56/60 (93.3%) were <5 years of age. Wheezing was present in 21/60 (35.0%) of the children with atypical pneumonia and in 128/325 (39.4%) with typical pneumonia. The factors associated with M. pneumonia were female sex (AOR 1.94, 95% CI 1.22-3.08, p < 0.001), age ≥12 months (AOR 2.73, 95% CI 1.53-4.87, p = 0.01) and a history of prematurity (AOR 2.07, 95% CI 1.23-3.49, p = 0.01). Mortality was 17/352 (4.8%) and, of these, 4/17 (23.5%) had M. pneumonia.
CONCLUSION: : M. pneumonia is common in young children , especially females above 2 years and those with history of prematurity. It presents with severe symptoms. The results of the study highlight the importance of considering atypical bacteria in under-5s with the symptoms of pneumonia.

Entities:  

Keywords:  Mycoplasma pneumonia; atypical pneumonia; outcome; prevalence

Mesh:

Year:  2021        PMID: 34743675      PMCID: PMC8791631          DOI: 10.1080/20469047.2021.1980698

Source DB:  PubMed          Journal:  Paediatr Int Child Health        ISSN: 2046-9047            Impact factor:   1.990


  29 in total

Review 1.  Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks' gestational age.

Authors:  Andrew A Colin; Cynthia McEvoy; Robert G Castile
Journal:  Pediatrics       Date:  2010-06-07       Impact factor: 7.124

Review 2.  Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Angela Gentile; Ariel Bardach; Agustín Ciapponi; Sebastian Garcia-Marti; Patricia Aruj; Demian Glujovsky; Juan Ignacio Calcagno; Agustina Mazzoni; Romulo Ernesto Colindres
Journal:  Int J Infect Dis       Date:  2011-11-06       Impact factor: 3.623

3.  Chlamydophila pneumoniae, Mycoplasma pneumoniae, and influenza in children with respiratory infections in Alexandria, Egypt.

Authors:  Tiziana Grassi; Fabiola Mancini; Alessandra Ciervo; Maria Fenicia Vescio; Abeer Ghazal; Housam Ashour; Ezzeldin Saleh; Mahmoud El Zalabani; Isabella Donatelli; Gamal El Sawaf; Giovanni Rezza
Journal:  J Infect Dev Ctries       Date:  2014-03-13       Impact factor: 0.968

4.  Mycoplasma pneumoniae infection in a pediatric population: analysis of soluble immune markers as risk factors for asthma.

Authors:  Jaythoon Hassan; Fiona Irwin; Seamus Dooley; Jeff Connell
Journal:  Hum Immunol       Date:  2008-10-07       Impact factor: 2.850

5.  Consecutive screening and enrollment in clinical trials: the way to representative patient samples?

Authors:  M Bjørn; C Brendstrup; S Karlsen; J E Carlsen
Journal:  J Card Fail       Date:  1998-09       Impact factor: 5.712

6.  Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study.

Authors:  Grace Ndeezi; Charles Kiyaga; Arielle G Hernandez; Deogratias Munube; Thad A Howard; Isaac Ssewanyana; Jesca Nsungwa; Sarah Kiguli; Christopher M Ndugwa; Russell E Ware; Jane R Aceng
Journal:  Lancet Glob Health       Date:  2016-01-29       Impact factor: 26.763

7.  Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.

Authors:  Eric D McCollum; Bejoy Nambiar; Rashid Deula; Beatiwel Zadutsa; Austin Bondo; Carina King; James Beard; Harry Liyaya; Limangeni Mankhambo; Marzia Lazzerini; Charles Makwenda; Gibson Masache; Naor Bar-Zeev; Peter N Kazembe; Charles Mwansambo; Norman Lufesi; Anthony Costello; Ben Armstrong; Tim Colbourn
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

8.  Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.

Authors: 
Journal:  Lancet       Date:  2019-06-27       Impact factor: 202.731

9.  Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia.

Authors:  Yeon Jin Cho; Mi Seon Han; Woo Sun Kim; Eun Hwa Choi; Young Hun Choi; Ki Wook Yun; SeungHyun Lee; Jung-Eun Cheon; In-One Kim; Hoan Jong Lee
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

10.  Clinical manifestations in infants and children with Mycoplasma pneumoniae infection.

Authors:  Mia Johanna Søndergaard; Martin Barfred Friis; Dennis Schrøder Hansen; Inger Merete Jørgensen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.